HIGHLIGHTS
- who: Wei-Chun Huang and colleagues from the Division of Pulmonary and Critical Care, Department of Internal Medicine, China Medical University Hospital, No2, Yude Road, North District, Taichung, Taiwan have published the research work: Differences in Pulmonary Function Improvement after Once-Daily LABA/LAMA Fixed-Dose Combinations in Patients with COPD, in the Journal: (JOURNAL)
- what: This study reported that pulmonary function improvement was significantly affected by the different types of medication. In the current study, medication delivered via a DPI (IND/GLY and UMEC/VIL) resulted in a no significantly greater improvement in FEV1 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.